BTI
AMPH icon

Blue Trust Inc’s Amphastar Pharmaceuticals AMPH Stock Holding History

Blue Trust Inc’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.5K Buy
1,607
+367
+30% +$8.98K ﹤0.01% 1504
2025
Q4 		$33.2K Sell
1,240
-528
-30% -$13.6K ﹤0.01% 1501
2025
Q3 		$47.1K Sell
1,768
-8
-0.5% -$207 ﹤0.01% 1435
2025
Q2 		$40.8K Buy
1,776
+317
+22% +$7.87K ﹤0.01% 1502
2025
Q1 		$42.3K Buy
1,459
+243
+20% +$7.76K ﹤0.01% 1441
2024
Q4 		$45.1K Sell
1,216
-269
-18% -$12.3K ﹤0.01% 1388
2024
Q3 		$59.4K Sell
1,485
-119
-7% -$5.22K ﹤0.01% 1493
2024
Q2 		$70.4K Buy
1,604
+309
+24% +$12.8K ﹤0.01% 1115
2024
Q1 		$56.9K Buy
1,295
+219
+20% +$11.3K ﹤0.01% 873
2023
Q4 		$49K Sell
1,076
-122
-10% -$6.41K ﹤0.01% 942
2023
Q3 		$69K Buy
1,198
+1,068
+822% +$58.3K ﹤0.01% 740
2023
Q2 		$5K Sell
130
-393
-75% -$17.4K ﹤0.01% 1507
2023
Q1 		$15K Sell
523
-88
-14% -$2.88K ﹤0.01% 1472
2022
Q4 		$17K Buy
611
+330
+117% +$9.58K ﹤0.01% 1339
2022
Q3 		$10K Buy
281
+150
+115% +$4.9K ﹤0.01% 1319
2022
Q2 		$5K Buy
+131
New +$4.67K ﹤0.01% 1416

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Blue Trust Inc's AMPH Position: Q1 2026 in Review

Blue Trust Inc increased its Amphastar Pharmaceuticals (AMPH) stake by 30% in Q1 2026, buying an estimated $8.98K and bringing the position to 1,607 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1504.

Blue Trust Inc first reported a position in AMPH in Q2 2022 and has held it in 16 quarters since. The position peaked at $70.4K in Q2 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Blue Trust Inc held 1,607 shares of Amphastar Pharmaceuticals worth $31.5K as of Q1 2026.
  • Blue Trust Inc bought 367 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $8.98K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #1504 holding.
  • Blue Trust Inc first reported a position in Amphastar Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • Blue Trust Inc's Amphastar Pharmaceuticals position peaked at $70.4K in Q2 2024.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.